These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 4938286)
1. [Hypoglycemic action of fenfluramine in obese diabetics]. De Sereday MS; Efron HR; De Compte DV; Raffo del Campo MA Prensa Med Argent; 1971 Jul; 58(20):1030-3. PubMed ID: 4938286 [No Abstract] [Full Text] [Related]
2. Phenformin compared with fenfluramine in the treatment of obese diabetic patients. Kesson CM; Ireland JT Practitioner; 1976 May; 216(1295):577-80. PubMed ID: 781656 [No Abstract] [Full Text] [Related]
4. [New aspects in the management of overweight diabetics]. Brumby KH Ther Ggw; 1979 Apr; 118(4):558-66. PubMed ID: 462386 [No Abstract] [Full Text] [Related]
5. [The treatment of the obese non-insulin-dependent patient with d-fenfluramine]. Daniele E; Coco MP Clin Ter; 1996 Apr; 147(4):199-204. PubMed ID: 8766352 [TBL] [Abstract][Full Text] [Related]
6. Relative unresponsiveness of obese diabetic compared to obese non-diabetic subjects to the weight-reducing effect of fenfluramine. Otim MA East Afr Med J; 1977 Feb; 54(2):91-5. PubMed ID: 885093 [No Abstract] [Full Text] [Related]
7. Assessment of new formulation of fenfluramine in the management of the obese, diabetic African. Wilton D Postgrad Med J; 1975; 51 Suppl 1():138-9. PubMed ID: 1219673 [No Abstract] [Full Text] [Related]
8. [Is fenfluramine suitable as a therapeutic principle in obese aged diabetics? (end)]. Förster H; Huth K; Koch E; Tunali G Fortschr Med; 1979 Feb; 97(6):259-62. PubMed ID: 428867 [No Abstract] [Full Text] [Related]
9. 780SE in the management of disorders of lipid and glucose metabolism. Riveline B Postgrad Med J; 1975; 51 Suppl 1():162-4. PubMed ID: 1219674 [No Abstract] [Full Text] [Related]
10. Prolonged-action fenfluramine in non-diabetic patients with refractory obesity. Galloway DB; Logie AW; Petrie JC Postgrad Med J; 1975; 51 Suppl 1():155-7. PubMed ID: 768957 [No Abstract] [Full Text] [Related]
11. [Clinical trial of a new long-acting fenfluramine in the treatment of obesity]. Pugnoli C; Bandini L; Caronna S; Ciarlini E; Magnati G; Strata A; Tirelli F G Clin Med; 1978 Nov; 59(11):486-510. PubMed ID: 369930 [No Abstract] [Full Text] [Related]
17. Successful appetite suppression therapy with fenfluramine and phentermine in the obese diabetic transplant patient. Khan M; Lum CT; Rao V Transplant Proc; 1995 Feb; 27(1):975-6. PubMed ID: 7879251 [No Abstract] [Full Text] [Related]
18. Trial of a long-acting preparation of diethylpropion in obese diabetics. Williams J Practitioner; 1968 Mar; 200(197):411-4. PubMed ID: 4868835 [No Abstract] [Full Text] [Related]
19. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity]. Liebermeister H; Probst G; Jahnke K Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324 [No Abstract] [Full Text] [Related]
20. A six month study of a carbohydrate restricted diet in the management of maturity-onset diabetes and an evaluation of fenfluramine in patients unresponsive to this diet. Luntz GR; Reuter CJ Postgrad Med J; 1975; 51 Suppl 1():133-7. PubMed ID: 1219671 [No Abstract] [Full Text] [Related] [Next] [New Search]